Latest filing published 20 Aug 2026 for Cytek Biosciences, Inc.. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Wenbin Jiang appears in our data through filings on Cytek Biosciences, Inc. shares, published by SEC (Form 4). The record holds 52 filings, for trades running from 22 July 2021 to 18 August 2026.
Every open-market trade on record is a sale: 19 sales worth €3.7M. Outside the open market, there are 4 share grants and 24 option exercises.
The latest filing, published on 20 August 2026, reports an option exercise in Cytek Biosciences, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 52 declarations